Philadelphia University + Thomas Jefferson University

Farber, John

< Back

Profile

John L. Farber, MD

John L. Farber, MD

Contact Dr. Farber

132 South 10th Street
Main Building, Suite 285
Philadelphia, PA 19107

(215) 503-5028
(215) 923-2218 fax

Research & Clinical Interests

Cell Death; Cellular Pathology; Diabetes; Digestive Diseases And Disorders; Digestive System; Kidney (Renal) Functions; Kidney Disease; Mitochondria; Necrosis; Urology

Biochemical mechanisms of cell injury in ischemia of liver cell necrosis; biochemical toxicology of activated oxygen; chemical carcinogenesis.

Publications

Most Recent Peer-Reviewed Publications

  1. Transplant glomerulopathy
  2. The Nephrotoxicity of Vancomycin
  3. Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neopl
  4. Membranous nephropathy in the kidney allograft
  5. Rapidly Fatal Hemophagocytic Lymphohistiocytosis Developing Within Six Days Following Deceased-Donor Renal Transplantation: Case Report
  6. Hemophagocytic lymphohistiocytosis: an update for nephrologists
  7. Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes
  8. The humoral theory of transplantation: Epitope analysis and the pathogenicity of HLA antibodies
  9. Zinc intake, microRNA dysregulation, and esophageal cancer
  10. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency
  11. Humoral Immune Response and Allograft Function in Kidney Transplantation
  12. Humoral immunity in renal transplantation: Epitopes, Cw and DP, and complement-activating capability - an update
  13. Repression of esophageal neoplasia and inflammatory signaling by anti-MIR-31 delivery in vivo
  14. Posttransplantation normoglycemic diabetic nephropathy: The role of the allograft insulin resistance-a case report
  15. Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts
  16. The specificity of acute and chronic microvascular alterations in renal allografts
  17. GSK-3α is a central regulator of age-related pathologies in mice
  18. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature
  19. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer
  20. CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy